| View |
|
DR-XY40800
|
Anastrozole
|
Anazole
|
1mg
|
Film-Coated Tablet
|
Aromatase Inhibitor
|
Laboratories Richmond S.A.C.I.F.
|
Argentina
|
Automatic Renewal
|
21 January 2022
|
02 April 2027
|
| View |
|
DR-XY40801
|
Mebendazole
|
Antiox
|
500 mg
|
Chewable tablet
|
Anthelmintics (Benzimidazole derivatives)
|
Janssen Korea ltd.
|
Korea
|
Renewal
|
19 April 2022
|
02 April 2027
|
| View |
|
DR-XY40805
|
Guiafenesin + Salbutamol
|
Asmalex
|
100 mg / 2 mg
|
Capsule
|
Expectorant/Selective Beta-2-adrenoreceptor Antagonist
|
Lloyd Laboratories, Inc.
|
Philippines
|
Automatic Renewal
|
08 March 2022
|
03 April 2027
|
| View |
|
DR-XY40806
|
Tamsulosin Hydrochloride
|
None
|
200mg
|
Capsule
|
-
|
UNILAB, Inc.
|
Philippines
|
-
|
11 May 2020
|
03 April 2025
|
| View |
|
DR-XY40810
|
Fexofenadine Hydrochloride
|
Fenofex
|
120 mg
|
Film-Coated Tablet
|
Antihistamine
|
Geofman Pharmaceuticals
|
Pakistan
|
Automatic Renewal
|
03 March 2022
|
03 April 2027
|
| View |
|
DR-XY40811
|
Fexofenadine Hydrochloride
|
Fenofex
|
60 mg
|
Film-Coated Tablet
|
Antihistamines
|
Geofman Pharmaceuticals
|
Pakistan
|
Automatic Renewal
|
14 March 2022
|
03 April 2027
|
| View |
|
DR-XY40832
|
Verapamil Hydrochloride
|
Isoptin SR
|
240mg
|
Sustained-release Tablet
|
Calcium Channel Blocker
|
AbbVie Deutschland GmbH & Co. KG
|
Germany
|
Automatic Renewal
|
28 February 2022
|
18 April 2027
|
| View |
|
DR-XY40836
|
Cetirizine Dihydrochloride
|
Rinozine
|
10 mg
|
Film-Coated Tablet
|
Antihistamine
|
Pharmasant Laboratories Co., Ltd.
|
Thailand
|
Automatic Renewal
|
02 March 2022
|
19 April 2027
|
| View |
|
DR-XY40837
|
Tarceva
|
Erlotinib
|
150 mg
|
Film-Coated Tablet
|
Antineoplastic Agent (Protein Kinase Inhibitor)
|
Roche S.p.A.
|
Italy
|
Renewal
|
19 April 2022
|
20 April 2027
|
| View |
|
DR-XY40838
|
Erlotinib
|
Tarceva
|
100 mg
|
Film-Coated Tablet
|
Antineoplastic Agent (Protein Kinase Inhibitor)
|
Roche S.p.A.
|
Italy
|
Automatic Renewal
|
16 March 2022
|
20 April 2027
|
| View |
|
DR-XY40848
|
Meloxicam
|
Osteoflam
|
7.5 mg
|
Tablet
|
Non-Steroidal Anti-inflammatory Drug
|
Bal Pharma Limited
|
India
|
Automatic Renewal
|
07 March 2022
|
02 May 2027
|
| View |
|
DR-XY40849
|
Meloxicam
|
Osteoflam
|
15 mg
|
Tablet
|
Non-Steroidal Anti-inflammatory Drug (NSAID)
|
Bal Pharma Limited
|
India
|
Automatic Renewal
|
09 March 2022
|
02 May 2027
|
| View |
|
DR-XY40850
|
Rivaroxaban
|
Xarelto
|
15 mg
|
Film-Coated Tablet
|
-
|
Bayer AG
|
Germany
|
-
|
26 March 2020
|
25 April 2025
|
| View |
|
DR-XY40851
|
Rivaroxaban
|
Xarelto
|
20 mg
|
Film-Coated Tablet
|
-
|
Bayer AG
|
Germany
|
-
|
13 April 2020
|
25 April 2025
|
| View |
|
DR-XY40852
|
Cefixime (as trihydrate)
|
Vamocef
|
20 mg/mL
|
Powder For Suspension (Oral Drops)
|
Antibacterials
|
Lloyd Laboratories,Inc.
|
Philippines
|
Renewal
|
30 May 2022
|
03 May 2027
|
| View |
|
DR-XY40869
|
Montelukast ( As Sodium)
|
AUROHEX
|
4mg
|
Chewable Tablet
|
Leukotriene Receptor Antagonist
|
Flamingo Pharmaceuticals Limited
|
India
|
Renewal
|
19 April 2022
|
24 July 2027
|
| View |
|
DR-XY40870
|
Cabazitaxel
|
Jevtana
|
60 mg/1.5 mL
|
Concentrate for Solution for Injection (I. V.)
|
Antineoplastic (Taxane)
|
Sanofi-Aventis Deutschland GmbH
|
Germany
|
Initial (from Monitored release)
|
31 May 2022
|
13 January 2027
|
| View |
|
DR-XY40875
|
Cefuroxime (As Axetil)
|
Kefsyn
|
250 mg/5 mL
|
Granules For Oral Suspension
|
Antibacterial (Second Generation Cephalosporin)
|
Lloyd Laboratories, Inc.
|
Philippines
|
Automatic Renewal
|
03 March 2022
|
17 May 2027
|
| View |
|
DR-XY40877
|
Granisetron
|
Frezitron
|
1mg/ml
|
Concentrate for Solution for IV Infusion
|
Anti-emetics and Anti-nauseants (Serotonin-5HT Antagonists)
|
Labesfal - Laboratorios Almiro S.A.
|
Portugal
|
Renewal
|
10 May 2022
|
15 May 2027
|
| View |
|
DR-XY40881
|
Alfacalcidol
|
Philvita Alfa D
|
500 mg
|
Softgel Capsule
|
Bone Metabolism Regulators
|
Phil Inter Pharma Co., Ltd
|
Vietnam
|
Renewal
|
24 June 2022
|
16 May 2027
|